nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Thiotepa—sarcoma	0.248	0.458	CbGbCtD
Avanafil—CYP3A4—Mitoxantrone—sarcoma	0.107	0.197	CbGbCtD
Avanafil—CYP3A4—Vincristine—sarcoma	0.0735	0.136	CbGbCtD
Avanafil—CYP3A4—Etoposide—sarcoma	0.0673	0.124	CbGbCtD
Avanafil—PDE5A—pulmonary artery—sarcoma	0.0475	0.483	CbGeAlD
Avanafil—CYP3A4—Doxorubicin—sarcoma	0.0459	0.0847	CbGbCtD
Avanafil—PDE5A—endothelium—sarcoma	0.0149	0.151	CbGeAlD
Avanafil—PDE5A—hematopoietic system—sarcoma	0.0073	0.0743	CbGeAlD
Avanafil—PDE5A—connective tissue—sarcoma	0.00703	0.0715	CbGeAlD
Avanafil—PDE5A—smooth muscle tissue—sarcoma	0.00643	0.0654	CbGeAlD
Avanafil—PDE5A—tendon—sarcoma	0.00483	0.0492	CbGeAlD
Avanafil—PDE5A—testis—sarcoma	0.004	0.0407	CbGeAlD
Avanafil—PDE5A—lymph node—sarcoma	0.0029	0.0295	CbGeAlD
Avanafil—CYP3A4—hematopoietic system—sarcoma	0.00228	0.0232	CbGeAlD
Avanafil—Myalgia—Thiotepa—sarcoma	0.00148	0.00413	CcSEcCtD
Avanafil—Arthralgia—Thiotepa—sarcoma	0.00148	0.00413	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00147	0.0041	CcSEcCtD
Avanafil—Myalgia—Dactinomycin—sarcoma	0.00147	0.00409	CcSEcCtD
Avanafil—Back pain—Mitoxantrone—sarcoma	0.00146	0.00405	CcSEcCtD
Avanafil—Influenza like illness—Doxorubicin—sarcoma	0.00144	0.00401	CcSEcCtD
Avanafil—Urinary tract disorder—Etoposide—sarcoma	0.00142	0.00395	CcSEcCtD
Avanafil—Agitation—Vincristine—sarcoma	0.00142	0.00395	CcSEcCtD
Avanafil—Vision blurred—Mitoxantrone—sarcoma	0.00142	0.00394	CcSEcCtD
Avanafil—Infection—Thiotepa—sarcoma	0.00141	0.00393	CcSEcCtD
Avanafil—Urethral disorder—Etoposide—sarcoma	0.00141	0.00392	CcSEcCtD
Avanafil—Infection—Dactinomycin—sarcoma	0.0014	0.0039	CcSEcCtD
Avanafil—Nervous system disorder—Thiotepa—sarcoma	0.0014	0.00388	CcSEcCtD
Avanafil—Vertigo—Vincristine—sarcoma	0.00139	0.00386	CcSEcCtD
Avanafil—Tachycardia—Thiotepa—sarcoma	0.00139	0.00386	CcSEcCtD
Avanafil—Skin disorder—Thiotepa—sarcoma	0.00138	0.00384	CcSEcCtD
Avanafil—Eye disorder—Etoposide—sarcoma	0.00134	0.00374	CcSEcCtD
Avanafil—Diabetes mellitus—Epirubicin—sarcoma	0.00134	0.00372	CcSEcCtD
Avanafil—Flushing—Etoposide—sarcoma	0.00134	0.00371	CcSEcCtD
Avanafil—Cardiac disorder—Etoposide—sarcoma	0.00134	0.00371	CcSEcCtD
Avanafil—Hypertension—Vincristine—sarcoma	0.00133	0.00371	CcSEcCtD
Avanafil—Myalgia—Vincristine—sarcoma	0.00132	0.00366	CcSEcCtD
Avanafil—Cough—Mitoxantrone—sarcoma	0.00131	0.00365	CcSEcCtD
Avanafil—Angiopathy—Etoposide—sarcoma	0.00131	0.00363	CcSEcCtD
Avanafil—Hypertension—Mitoxantrone—sarcoma	0.0013	0.00361	CcSEcCtD
Avanafil—Immune system disorder—Etoposide—sarcoma	0.0013	0.00361	CcSEcCtD
Avanafil—Mediastinal disorder—Etoposide—sarcoma	0.0013	0.0036	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Thiotepa—sarcoma	0.0013	0.0036	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00129	0.00358	CcSEcCtD
Avanafil—Chest pain—Mitoxantrone—sarcoma	0.00128	0.00356	CcSEcCtD
Avanafil—Myalgia—Mitoxantrone—sarcoma	0.00128	0.00356	CcSEcCtD
Avanafil—Arthralgia—Mitoxantrone—sarcoma	0.00128	0.00356	CcSEcCtD
Avanafil—Somnolence—Thiotepa—sarcoma	0.00127	0.00352	CcSEcCtD
Avanafil—Infection—Vincristine—sarcoma	0.00125	0.00348	CcSEcCtD
Avanafil—Dyspepsia—Thiotepa—sarcoma	0.00125	0.00348	CcSEcCtD
Avanafil—Hot flush—Epirubicin—sarcoma	0.00125	0.00346	CcSEcCtD
Avanafil—Diabetes mellitus—Doxorubicin—sarcoma	0.00124	0.00345	CcSEcCtD
Avanafil—Nervous system disorder—Vincristine—sarcoma	0.00124	0.00344	CcSEcCtD
Avanafil—Menopausal symptoms—Epirubicin—sarcoma	0.00124	0.00343	CcSEcCtD
Avanafil—Gastrointestinal disorder—Thiotepa—sarcoma	0.00123	0.00341	CcSEcCtD
Avanafil—Fatigue—Thiotepa—sarcoma	0.00123	0.00341	CcSEcCtD
Avanafil—Infection—Mitoxantrone—sarcoma	0.00122	0.00339	CcSEcCtD
Avanafil—Fatigue—Dactinomycin—sarcoma	0.00122	0.00338	CcSEcCtD
Avanafil—Constipation—Thiotepa—sarcoma	0.00122	0.00338	CcSEcCtD
Avanafil—Back pain—Etoposide—sarcoma	0.00121	0.00337	CcSEcCtD
Avanafil—Muscle spasms—Etoposide—sarcoma	0.0012	0.00335	CcSEcCtD
Avanafil—Tachycardia—Mitoxantrone—sarcoma	0.0012	0.00333	CcSEcCtD
Avanafil—Hypoglycaemia—Epirubicin—sarcoma	0.00119	0.00332	CcSEcCtD
Avanafil—Skin disorder—Mitoxantrone—sarcoma	0.00119	0.00332	CcSEcCtD
Avanafil—Hypotension—Vincristine—sarcoma	0.00118	0.00328	CcSEcCtD
Avanafil—CYP3A4—liver—sarcoma	0.00118	0.012	CbGeAlD
Avanafil—Pain in extremity—Epirubicin—sarcoma	0.00117	0.00324	CcSEcCtD
Avanafil—Hot flush—Doxorubicin—sarcoma	0.00115	0.0032	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Vincristine—sarcoma	0.00115	0.00319	CcSEcCtD
Avanafil—Hypotension—Mitoxantrone—sarcoma	0.00115	0.00319	CcSEcCtD
Avanafil—Menopausal symptoms—Doxorubicin—sarcoma	0.00114	0.00318	CcSEcCtD
Avanafil—Insomnia—Vincristine—sarcoma	0.00114	0.00317	CcSEcCtD
Avanafil—Vertigo—Etoposide—sarcoma	0.00113	0.00313	CcSEcCtD
Avanafil—Body temperature increased—Thiotepa—sarcoma	0.00112	0.00313	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00112	0.00311	CcSEcCtD
Avanafil—Body temperature increased—Dactinomycin—sarcoma	0.00112	0.0031	CcSEcCtD
Avanafil—Hypoglycaemia—Doxorubicin—sarcoma	0.00111	0.00307	CcSEcCtD
Avanafil—Cough—Etoposide—sarcoma	0.00109	0.00304	CcSEcCtD
Avanafil—Somnolence—Mitoxantrone—sarcoma	0.00109	0.00304	CcSEcCtD
Avanafil—Blood creatinine increased—Epirubicin—sarcoma	0.00109	0.00304	CcSEcCtD
Avanafil—Gastrointestinal disorder—Vincristine—sarcoma	0.00109	0.00303	CcSEcCtD
Avanafil—Fatigue—Vincristine—sarcoma	0.00109	0.00302	CcSEcCtD
Avanafil—Dyspepsia—Mitoxantrone—sarcoma	0.00108	0.00301	CcSEcCtD
Avanafil—Hypertension—Etoposide—sarcoma	0.00108	0.003	CcSEcCtD
Avanafil—Constipation—Vincristine—sarcoma	0.00108	0.003	CcSEcCtD
Avanafil—Pain in extremity—Doxorubicin—sarcoma	0.00108	0.003	CcSEcCtD
Avanafil—Chest pain—Etoposide—sarcoma	0.00107	0.00296	CcSEcCtD
Avanafil—Fatigue—Mitoxantrone—sarcoma	0.00106	0.00294	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00106	0.00294	CcSEcCtD
Avanafil—Breast disorder—Epirubicin—sarcoma	0.00105	0.00293	CcSEcCtD
Avanafil—Constipation—Mitoxantrone—sarcoma	0.00105	0.00292	CcSEcCtD
Avanafil—Nasopharyngitis—Epirubicin—sarcoma	0.00104	0.0029	CcSEcCtD
Avanafil—Gastritis—Epirubicin—sarcoma	0.00103	0.00287	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00103	0.00286	CcSEcCtD
Avanafil—Asthenia—Thiotepa—sarcoma	0.00102	0.00284	CcSEcCtD
Avanafil—Infection—Etoposide—sarcoma	0.00102	0.00282	CcSEcCtD
Avanafil—Asthenia—Dactinomycin—sarcoma	0.00101	0.00282	CcSEcCtD
Avanafil—Blood creatinine increased—Doxorubicin—sarcoma	0.00101	0.00281	CcSEcCtD
Avanafil—Influenza—Epirubicin—sarcoma	0.00101	0.0028	CcSEcCtD
Avanafil—Pruritus—Thiotepa—sarcoma	0.00101	0.0028	CcSEcCtD
Avanafil—Tachycardia—Etoposide—sarcoma	0.000998	0.00277	CcSEcCtD
Avanafil—Body temperature increased—Vincristine—sarcoma	0.000998	0.00277	CcSEcCtD
Avanafil—Skin disorder—Etoposide—sarcoma	0.000993	0.00276	CcSEcCtD
Avanafil—Angina pectoris—Epirubicin—sarcoma	0.000982	0.00273	CcSEcCtD
Avanafil—Breast disorder—Doxorubicin—sarcoma	0.000975	0.00271	CcSEcCtD
Avanafil—Diarrhoea—Thiotepa—sarcoma	0.000974	0.00271	CcSEcCtD
Avanafil—Body temperature increased—Mitoxantrone—sarcoma	0.000972	0.0027	CcSEcCtD
Avanafil—Bronchitis—Epirubicin—sarcoma	0.000969	0.00269	CcSEcCtD
Avanafil—Diarrhoea—Dactinomycin—sarcoma	0.000966	0.00269	CcSEcCtD
Avanafil—Nasopharyngitis—Doxorubicin—sarcoma	0.000965	0.00268	CcSEcCtD
Avanafil—Hypotension—Etoposide—sarcoma	0.000955	0.00265	CcSEcCtD
Avanafil—Gastritis—Doxorubicin—sarcoma	0.000955	0.00265	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000951	0.00264	CcSEcCtD
Avanafil—Dizziness—Thiotepa—sarcoma	0.000941	0.00262	CcSEcCtD
Avanafil—Upper respiratory tract infection—Epirubicin—sarcoma	0.000937	0.0026	CcSEcCtD
Avanafil—Influenza—Doxorubicin—sarcoma	0.000932	0.00259	CcSEcCtD
Avanafil—Pollakiuria—Epirubicin—sarcoma	0.000931	0.00259	CcSEcCtD
Avanafil—Weight increased—Epirubicin—sarcoma	0.000917	0.00255	CcSEcCtD
Avanafil—Somnolence—Etoposide—sarcoma	0.000909	0.00253	CcSEcCtD
Avanafil—Angina pectoris—Doxorubicin—sarcoma	0.000908	0.00252	CcSEcCtD
Avanafil—Asthenia—Vincristine—sarcoma	0.000905	0.00252	CcSEcCtD
Avanafil—Vomiting—Thiotepa—sarcoma	0.000905	0.00251	CcSEcCtD
Avanafil—Infestation NOS—Epirubicin—sarcoma	0.000898	0.0025	CcSEcCtD
Avanafil—Infestation—Epirubicin—sarcoma	0.000898	0.0025	CcSEcCtD
Avanafil—Vomiting—Dactinomycin—sarcoma	0.000898	0.0025	CcSEcCtD
Avanafil—Rash—Thiotepa—sarcoma	0.000897	0.00249	CcSEcCtD
Avanafil—Bronchitis—Doxorubicin—sarcoma	0.000897	0.00249	CcSEcCtD
Avanafil—Dermatitis—Thiotepa—sarcoma	0.000896	0.00249	CcSEcCtD
Avanafil—Headache—Thiotepa—sarcoma	0.000892	0.00248	CcSEcCtD
Avanafil—Rash—Dactinomycin—sarcoma	0.000891	0.00247	CcSEcCtD
Avanafil—Gastrointestinal disorder—Etoposide—sarcoma	0.000883	0.00245	CcSEcCtD
Avanafil—Asthenia—Mitoxantrone—sarcoma	0.000882	0.00245	CcSEcCtD
Avanafil—Fatigue—Etoposide—sarcoma	0.000881	0.00245	CcSEcCtD
Avanafil—Constipation—Etoposide—sarcoma	0.000874	0.00243	CcSEcCtD
Avanafil—Urinary tract infection—Epirubicin—sarcoma	0.000873	0.00243	CcSEcCtD
Avanafil—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000867	0.00241	CcSEcCtD
Avanafil—Diarrhoea—Vincristine—sarcoma	0.000863	0.0024	CcSEcCtD
Avanafil—Pollakiuria—Doxorubicin—sarcoma	0.000861	0.00239	CcSEcCtD
Avanafil—Haematuria—Epirubicin—sarcoma	0.000857	0.00238	CcSEcCtD
Avanafil—Weight increased—Doxorubicin—sarcoma	0.000849	0.00236	CcSEcCtD
Avanafil—Epistaxis—Epirubicin—sarcoma	0.000847	0.00235	CcSEcCtD
Avanafil—Nausea—Thiotepa—sarcoma	0.000845	0.00235	CcSEcCtD
Avanafil—Sinusitis—Epirubicin—sarcoma	0.000843	0.00234	CcSEcCtD
Avanafil—Diarrhoea—Mitoxantrone—sarcoma	0.000841	0.00234	CcSEcCtD
Avanafil—Nausea—Dactinomycin—sarcoma	0.000839	0.00233	CcSEcCtD
Avanafil—Dizziness—Vincristine—sarcoma	0.000834	0.00232	CcSEcCtD
Avanafil—Infestation NOS—Doxorubicin—sarcoma	0.000831	0.00231	CcSEcCtD
Avanafil—Infestation—Doxorubicin—sarcoma	0.000831	0.00231	CcSEcCtD
Avanafil—Body temperature increased—Etoposide—sarcoma	0.000808	0.00225	CcSEcCtD
Avanafil—Urinary tract infection—Doxorubicin—sarcoma	0.000808	0.00225	CcSEcCtD
Avanafil—Vomiting—Vincristine—sarcoma	0.000802	0.00223	CcSEcCtD
Avanafil—Urinary tract disorder—Epirubicin—sarcoma	0.000797	0.00221	CcSEcCtD
Avanafil—Rash—Vincristine—sarcoma	0.000796	0.00221	CcSEcCtD
Avanafil—Dermatitis—Vincristine—sarcoma	0.000795	0.00221	CcSEcCtD
Avanafil—Oedema peripheral—Epirubicin—sarcoma	0.000795	0.00221	CcSEcCtD
Avanafil—Haematuria—Doxorubicin—sarcoma	0.000793	0.0022	CcSEcCtD
Avanafil—Connective tissue disorder—Epirubicin—sarcoma	0.000793	0.0022	CcSEcCtD
Avanafil—Urethral disorder—Epirubicin—sarcoma	0.000791	0.0022	CcSEcCtD
Avanafil—Headache—Vincristine—sarcoma	0.000791	0.0022	CcSEcCtD
Avanafil—Epistaxis—Doxorubicin—sarcoma	0.000784	0.00218	CcSEcCtD
Avanafil—Vomiting—Mitoxantrone—sarcoma	0.000781	0.00217	CcSEcCtD
Avanafil—Sinusitis—Doxorubicin—sarcoma	0.00078	0.00217	CcSEcCtD
Avanafil—Rash—Mitoxantrone—sarcoma	0.000775	0.00215	CcSEcCtD
Avanafil—Dermatitis—Mitoxantrone—sarcoma	0.000774	0.00215	CcSEcCtD
Avanafil—Headache—Mitoxantrone—sarcoma	0.00077	0.00214	CcSEcCtD
Avanafil—Eye disorder—Epirubicin—sarcoma	0.000754	0.00209	CcSEcCtD
Avanafil—Nausea—Vincristine—sarcoma	0.00075	0.00208	CcSEcCtD
Avanafil—Cardiac disorder—Epirubicin—sarcoma	0.000749	0.00208	CcSEcCtD
Avanafil—Flushing—Epirubicin—sarcoma	0.000749	0.00208	CcSEcCtD
Avanafil—Urinary tract disorder—Doxorubicin—sarcoma	0.000737	0.00205	CcSEcCtD
Avanafil—Oedema peripheral—Doxorubicin—sarcoma	0.000735	0.00204	CcSEcCtD
Avanafil—Asthenia—Etoposide—sarcoma	0.000733	0.00204	CcSEcCtD
Avanafil—Connective tissue disorder—Doxorubicin—sarcoma	0.000733	0.00204	CcSEcCtD
Avanafil—Angiopathy—Epirubicin—sarcoma	0.000732	0.00203	CcSEcCtD
Avanafil—Urethral disorder—Doxorubicin—sarcoma	0.000732	0.00203	CcSEcCtD
Avanafil—Nausea—Mitoxantrone—sarcoma	0.00073	0.00203	CcSEcCtD
Avanafil—Immune system disorder—Epirubicin—sarcoma	0.000729	0.00202	CcSEcCtD
Avanafil—Mediastinal disorder—Epirubicin—sarcoma	0.000727	0.00202	CcSEcCtD
Avanafil—Pruritus—Etoposide—sarcoma	0.000723	0.00201	CcSEcCtD
Avanafil—Mental disorder—Epirubicin—sarcoma	0.000707	0.00196	CcSEcCtD
Avanafil—Malnutrition—Epirubicin—sarcoma	0.000702	0.00195	CcSEcCtD
Avanafil—Diarrhoea—Etoposide—sarcoma	0.000699	0.00194	CcSEcCtD
Avanafil—Eye disorder—Doxorubicin—sarcoma	0.000697	0.00194	CcSEcCtD
Avanafil—Cardiac disorder—Doxorubicin—sarcoma	0.000693	0.00192	CcSEcCtD
Avanafil—Flushing—Doxorubicin—sarcoma	0.000693	0.00192	CcSEcCtD
Avanafil—Back pain—Epirubicin—sarcoma	0.000679	0.00189	CcSEcCtD
Avanafil—Angiopathy—Doxorubicin—sarcoma	0.000677	0.00188	CcSEcCtD
Avanafil—Dizziness—Etoposide—sarcoma	0.000676	0.00188	CcSEcCtD
Avanafil—Muscle spasms—Epirubicin—sarcoma	0.000675	0.00188	CcSEcCtD
Avanafil—Immune system disorder—Doxorubicin—sarcoma	0.000674	0.00187	CcSEcCtD
Avanafil—Mediastinal disorder—Doxorubicin—sarcoma	0.000673	0.00187	CcSEcCtD
Avanafil—Vision blurred—Epirubicin—sarcoma	0.000662	0.00184	CcSEcCtD
Avanafil—Mental disorder—Doxorubicin—sarcoma	0.000654	0.00182	CcSEcCtD
Avanafil—Vomiting—Etoposide—sarcoma	0.00065	0.00181	CcSEcCtD
Avanafil—Malnutrition—Doxorubicin—sarcoma	0.00065	0.00181	CcSEcCtD
Avanafil—Agitation—Epirubicin—sarcoma	0.000645	0.00179	CcSEcCtD
Avanafil—Rash—Etoposide—sarcoma	0.000645	0.00179	CcSEcCtD
Avanafil—Dermatitis—Etoposide—sarcoma	0.000644	0.00179	CcSEcCtD
Avanafil—Headache—Etoposide—sarcoma	0.00064	0.00178	CcSEcCtD
Avanafil—Vertigo—Epirubicin—sarcoma	0.000631	0.00175	CcSEcCtD
Avanafil—Back pain—Doxorubicin—sarcoma	0.000628	0.00175	CcSEcCtD
Avanafil—Muscle spasms—Doxorubicin—sarcoma	0.000625	0.00174	CcSEcCtD
Avanafil—Palpitations—Epirubicin—sarcoma	0.00062	0.00172	CcSEcCtD
Avanafil—Cough—Epirubicin—sarcoma	0.000613	0.0017	CcSEcCtD
Avanafil—Vision blurred—Doxorubicin—sarcoma	0.000612	0.0017	CcSEcCtD
Avanafil—Nausea—Etoposide—sarcoma	0.000607	0.00169	CcSEcCtD
Avanafil—Hypertension—Epirubicin—sarcoma	0.000606	0.00168	CcSEcCtD
Avanafil—Arthralgia—Epirubicin—sarcoma	0.000598	0.00166	CcSEcCtD
Avanafil—Chest pain—Epirubicin—sarcoma	0.000598	0.00166	CcSEcCtD
Avanafil—Myalgia—Epirubicin—sarcoma	0.000598	0.00166	CcSEcCtD
Avanafil—Agitation—Doxorubicin—sarcoma	0.000597	0.00166	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000594	0.00165	CcSEcCtD
Avanafil—Dry mouth—Epirubicin—sarcoma	0.000585	0.00162	CcSEcCtD
Avanafil—Vertigo—Doxorubicin—sarcoma	0.000584	0.00162	CcSEcCtD
Avanafil—Palpitations—Doxorubicin—sarcoma	0.000574	0.0016	CcSEcCtD
Avanafil—Infection—Epirubicin—sarcoma	0.000569	0.00158	CcSEcCtD
Avanafil—Cough—Doxorubicin—sarcoma	0.000567	0.00158	CcSEcCtD
Avanafil—Nervous system disorder—Epirubicin—sarcoma	0.000562	0.00156	CcSEcCtD
Avanafil—Hypertension—Doxorubicin—sarcoma	0.000561	0.00156	CcSEcCtD
Avanafil—Tachycardia—Epirubicin—sarcoma	0.000559	0.00155	CcSEcCtD
Avanafil—Skin disorder—Epirubicin—sarcoma	0.000557	0.00155	CcSEcCtD
Avanafil—Myalgia—Doxorubicin—sarcoma	0.000553	0.00154	CcSEcCtD
Avanafil—Chest pain—Doxorubicin—sarcoma	0.000553	0.00154	CcSEcCtD
Avanafil—Arthralgia—Doxorubicin—sarcoma	0.000553	0.00154	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000549	0.00153	CcSEcCtD
Avanafil—Dry mouth—Doxorubicin—sarcoma	0.000541	0.0015	CcSEcCtD
Avanafil—Hypotension—Epirubicin—sarcoma	0.000535	0.00149	CcSEcCtD
Avanafil—Infection—Doxorubicin—sarcoma	0.000527	0.00146	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000522	0.00145	CcSEcCtD
Avanafil—Nervous system disorder—Doxorubicin—sarcoma	0.00052	0.00144	CcSEcCtD
Avanafil—Insomnia—Epirubicin—sarcoma	0.000518	0.00144	CcSEcCtD
Avanafil—Tachycardia—Doxorubicin—sarcoma	0.000517	0.00144	CcSEcCtD
Avanafil—Skin disorder—Doxorubicin—sarcoma	0.000515	0.00143	CcSEcCtD
Avanafil—Somnolence—Epirubicin—sarcoma	0.000509	0.00142	CcSEcCtD
Avanafil—Dyspepsia—Epirubicin—sarcoma	0.000504	0.0014	CcSEcCtD
Avanafil—Hypotension—Doxorubicin—sarcoma	0.000495	0.00138	CcSEcCtD
Avanafil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000495	0.00137	CcSEcCtD
Avanafil—Fatigue—Epirubicin—sarcoma	0.000494	0.00137	CcSEcCtD
Avanafil—Constipation—Epirubicin—sarcoma	0.00049	0.00136	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000483	0.00134	CcSEcCtD
Avanafil—Insomnia—Doxorubicin—sarcoma	0.00048	0.00133	CcSEcCtD
Avanafil—Somnolence—Doxorubicin—sarcoma	0.000471	0.00131	CcSEcCtD
Avanafil—Dyspepsia—Doxorubicin—sarcoma	0.000467	0.0013	CcSEcCtD
Avanafil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000458	0.00127	CcSEcCtD
Avanafil—Fatigue—Doxorubicin—sarcoma	0.000457	0.00127	CcSEcCtD
Avanafil—Constipation—Doxorubicin—sarcoma	0.000453	0.00126	CcSEcCtD
Avanafil—Body temperature increased—Epirubicin—sarcoma	0.000453	0.00126	CcSEcCtD
Avanafil—Body temperature increased—Doxorubicin—sarcoma	0.000419	0.00116	CcSEcCtD
Avanafil—Asthenia—Epirubicin—sarcoma	0.000411	0.00114	CcSEcCtD
Avanafil—Pruritus—Epirubicin—sarcoma	0.000405	0.00113	CcSEcCtD
Avanafil—Diarrhoea—Epirubicin—sarcoma	0.000392	0.00109	CcSEcCtD
Avanafil—Asthenia—Doxorubicin—sarcoma	0.00038	0.00106	CcSEcCtD
Avanafil—Dizziness—Epirubicin—sarcoma	0.000379	0.00105	CcSEcCtD
Avanafil—Pruritus—Doxorubicin—sarcoma	0.000375	0.00104	CcSEcCtD
Avanafil—Vomiting—Epirubicin—sarcoma	0.000364	0.00101	CcSEcCtD
Avanafil—Diarrhoea—Doxorubicin—sarcoma	0.000363	0.00101	CcSEcCtD
Avanafil—Rash—Epirubicin—sarcoma	0.000361	0.001	CcSEcCtD
Avanafil—Dermatitis—Epirubicin—sarcoma	0.000361	0.001	CcSEcCtD
Avanafil—Headache—Epirubicin—sarcoma	0.000359	0.000998	CcSEcCtD
Avanafil—Dizziness—Doxorubicin—sarcoma	0.000351	0.000974	CcSEcCtD
Avanafil—Nausea—Epirubicin—sarcoma	0.00034	0.000946	CcSEcCtD
Avanafil—Vomiting—Doxorubicin—sarcoma	0.000337	0.000937	CcSEcCtD
Avanafil—Rash—Doxorubicin—sarcoma	0.000334	0.000929	CcSEcCtD
Avanafil—Dermatitis—Doxorubicin—sarcoma	0.000334	0.000928	CcSEcCtD
Avanafil—Headache—Doxorubicin—sarcoma	0.000332	0.000923	CcSEcCtD
Avanafil—Nausea—Doxorubicin—sarcoma	0.000315	0.000875	CcSEcCtD
